WY
37
3
CTAS
42
2
ACN
54
4
AIZ
66
3
ROP
48
3
FLR
52
2
MMM
37
2
ABBV
48
2
PLD
40
2
LOW
46
3
AEE
56
5
ADI
59
2
GOOGL
66
2
JPM
62
3
MTB
40
2
PSX
27
2
LH
38
5
FTI
63
2
ZTS
40
2
MPC
31
3
WY
37
3
CTAS
42
2
ACN
54
4
AIZ
66
3
ROP
48
3
FLR
52
2
MMM
37
2
ABBV
48
2
PLD
40
2
LOW
46
3
AEE
56
5
ADI
59
2
GOOGL
66
2
JPM
62
3
MTB
40
2
PSX
27
2
LH
38
5
FTI
63
2
ZTS
40
2
MPC
31
3
Financhill
Back

Genmab AS Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
27

GMAB
Genmab AS

Last Price:
$20.46
Seasonality Move:
3.07%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 36.6% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $20.47. The Score for GMAB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 36.6% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Sell
27
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
32.88
52-Week Low:
19.85

Prediction Charts

Market Cap:
13B
Price in USD:
20.47
Volume:
454.7K
Beta:
0.70

Technical Analysis

SMA50:
21.73
SMA100:
23.86
SMA200:
26.06
52-Wk Change:
-34.89%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 20.47 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 21.95 21.85 21.97 21.80
Dec-6 21.73 21.81 22.02 21.72
Dec-9 21.98 22.11 22.33 21.96
Dec-10 22.17 21.83 22.19 21.81
Dec-11 21.75 21.55 21.78 21.50
Dec-12 20.98 20.65 21.15 20.65
Dec-13 20.46 20.17 20.48 20.12
Dec-16 19.94 20.02 20.37 19.85
Dec-17 19.95 20.03 20.28 19.90
Dec-18 20.76 20.14 21.03 20.12
Dec-19 20.25 20.09 20.33 19.99
Dec-20 20.22 20.31 20.43 20.13
Dec-23 20.71 20.76 20.86 20.50
Dec-24 20.65 20.47 20.71 20.40

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.28 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.